ApprovalTrail

Approval · Notice of Compliance 6882 · 1997

SUROLAN DROPS: Notice of Compliance 6882

Issued March 18, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6882
Date
March 18, 1997
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indication
Therapeutic class
Antibiotic, antifungal and anti-inflammatory

Products in this notice

BrandDINStatus today
SUROLAN DROPSNot yet assigned—

Medicinal ingredients